|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/00 | |
| C12P 21/08 |
| (11) | Number of the document | 2710032 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12790362.3 |
| Date of filing the European patent application | 2012-05-18 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/038628 |
| Date | 2012-05-18 |
| (87) | Number | WO 2012/162160 |
| Date | 2012-11-29 |
| (30) | Number | Date | Country code |
| 201161488523 P | 2011-05-20 | US | |
| 201261638134 P | 2012-04-25 | US |
| (72) |
BULIK, Dorota, A., US
BOSQUES, Carlos, J., US
COLLINS, Brian, Edward, US
HAINS, Maurice, Gaston, US
WASHBURN, Nathaniel, J., US
MEADOR, James, US
SMITH, Sean, US
BHATNAGAR, Naveen, US
|
| (73) |
Momenta Pharmaceuticals, Inc.,
301 Binney Street, Cambridge, MA 02142,
US
|
| (54) | MODIFIED GLYCOPROTEINS |
| MODIFIED GLYCOPROTEINS |